Metrics to compare | 0013Y0 | Peers Peers - average of corresponding metrics from companies closely matching 0013Y0: | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship Relationship0013Y0PeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | 0.0x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 0.0x | |
Price / LTM Sales | 0.0x | 0.0x | 0.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 0.0% | |
Fair Value Upside | Unlock | 0.0% | 0.0% | Unlock |
MSBIO, Inc. engages in the developing, manufacturing, and selling products that restores and treats damaged human tissues in South Korea. The company offers allograft tissue products, such as GenerFill H, MYBONE, MS Aminion, and MYDERM. It also provides medical devices, including MYGEN, a low antigenicity collagen injector; MS hydrolifting; MS Collagen, a low antigenicity atelocollagen; and MYGIS, a resorbable collagen membrane for GBR. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea.